FIA
PRPH

FNY Investment Advisers’s ProPhase Labs PRPH Stock Holding History

FNY Investment Advisers’s Portfolio PRPH Stock Details PRPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-5,940
Closed -$439K – 930
2021
Q1 		$439K Buy
+5,940
New +$570K 0.16% 111

Other funds holding PRPH

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
KSCM
Kamunting Street Capital Management Miami Beach, Florida $183M AUM 2.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
AWE
Avidian Wealth Enterprises Houston, Texas $3.62B AUM 24.8% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

FNY Investment Advisers's PRPH Position: Q2 2021 in Review

FNY Investment Advisers sold out of ProPhase Labs (PRPH) in Q2 2021, closing a stake of 5,940 shares — an estimated $439K sold.

FNY Investment Advisers first reported a position in PRPH in Q1 2021 and held it in 1 quarter. The position peaked at $439K in Q1 2021. 23 funds tracked by Wall St. Rank hold PRPH as of Q2 2021.

  • FNY Investment Advisers reported no remaining ProPhase Labs position as of Q2 2021 after selling out during the quarter.
  • FNY Investment Advisers sold 5,940 ProPhase Labs shares in Q2 2021, an estimated $439K.
  • FNY Investment Advisers first reported a position in ProPhase Labs in Q1 2021 and held it in 1 quarter.
  • FNY Investment Advisers's ProPhase Labs position peaked at $439K in Q1 2021.
  • 23 funds tracked by Wall St. Rank held ProPhase Labs as of Q2 2021.

Based on FNY Investment Advisers's 13F filing for Q2 2021, filed 14 Jul 2021.